Colorectal cancer screening with fecal occult blood testing;Cribado del cáncer colorrectal mediante test de sangre oculta en heces

Revista Espanola de Enfermedades Digestivas

Volumn 100, Issue 6, 2008, Pages 315-319

  Diaz Tasende J ^a   Marin Gabriel J C ^a  

^a HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD EXAMINATION; CANCER DIAGNOSIS; CANCER SCREENING; CANCER SURVIVAL; COLONOSCOPY; COLORECTAL CANCER; EDITORIAL; IMMUNOLOGICAL PROCEDURES; SIGMOIDOSCOPY;

COLORECTAL NEOPLASMS; HUMANS; MASS SCREENING; OCCULT BLOOD;

EID: 49749091680     PISSN: 11300108     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (24)

1. Noguera Aguilar JF, Vicens Arbona JC, Morales Soriano R, et al. Liver resection in metastatic colorectal cancer: A multidisciplinary approach. Rev Esp Enferm Dig 2005; 97 (11): 786-93.
2. Ruiz Ramos M, Escobar Pujolar A, Hermosín Bono T. Mortality from colorectal cancer in Andalusia: Findings in favour of mass screening. Rev Esp Enferm Dig 2005; 97 (2): 104-14.
3. Sonnenberg A, Delcò F, Inadomi JM. Cost-effectiveness of colonoscopy in screening for colorectal cancer. Ann Intern Med 2000; 133 (8): 573-84.
4. Frazier Al, Colditz GA, Fuchs CS, Kuntz KM. Cost-effectiveness of screening for colorectal cancer in the general population. JAMA 2000; 284 (15): 1954-61.
5. O'Leary BA, Olynyk JK, Neville AM, Platell CF. Cost-effectiveness of colorectal cancer screening: Comparison of community-based flexible sigmoidoscopy with fecal occult blood testing and colonoscopy. J Gastroenterol Hepatol 2004; 19 (1): 38-47.
6. Vijan S, Hwang EW, Hofer TP, Hayward RA. Which colon cancer screening test? A comparison of costs, effectiveness, and compliance. Am J Med 2001; 111 (8): 593-601.
7. Pignone M, Rich M, Teutsch SM, et al. Screening for colorectal cancer in adults at average risk: A summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med 2002; 137: 132-41.
8. Lieberman DA, Harford WV, Ahnen DJ, et al. One-time screening for colorectal cancer with combined fecal occult-blood testing and examination of the distal colon. N Engl J Med 2001; 345: 555-60.
9. Mandel JS, Bond JH, Church TR, et al. For the Minnesota Colon Cancer Control Study. Reducing mortality for colorectal cancer by screening for fecal occult blood. N Engl J Med 1993; 328: 1365-71.
10. Lang CA, Ransohoff DF. Fecal occult blood screening for colorectal cancer: Is mortality reduced by chance selection for screening colonoscopy? JAMA 1994; 271: 1011-3.
11. Hardcastle JD, Chamberlain JO, Robinson MHE, et al. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet 1996; 348: 1492-7.
12. Kronborg O, Fenger C, Olsen J, et al. Randomised study of screening for colorectal cancer with faecal-occult-blood test. Lancet 1996; 348: 1467-71.
13. Faivre J, Dancourt V, Lejeune C, et al. Reduction in colorectal cancer mortality by fecal occult blood screening in a French controlled study. Gastroenterology 2004; 126: 1674-80.
14. Morikawa T, Kato J, Yamaji Y, et al. A comparison of the immunochemical fecal occult blood test and total colonoscopy in the asymptomatic population. Gastroenterology 2005; 129: 422-8.
15. Vilkin A, Rozen P, Levi Z, et al. Performance characteristics and evaluation of an automated-developed and quantitative, immunochemical fecal occult blood screening test. Am J Gastroenterol 2005; 100: 2519-25.
16. Levi Z, Rozen P, Hazazi R, et al. A quantitative immunochemical fecal occult blood test for colorectal neoplasia. Ann Intern Med 2007; 146: 244-55.
17. Greenberg P, Bertario L, Gnauck R, et al. A prospective multicenter evaluation of new fecal occult blood tests in patients undergoing colonoscopy. Am J Gastroenterol 2000; 95: 1331-8.
18. Mandel JS, Church TR, Bond JH, et al. The effect of fecal occult-blood screening on the incidence of colorectal cancer. N Engl J Med 2000; 343: 1603-7.
19. Parekh M, Fendrick AM, Ladabaum U. As test evolve and cost of cancer care rise: Reappraising stool-based screening for colorectal neoplasia. Aliment Pharmacol Ther 2008; 27 (8): 697-712.
20. Klabunde CN, Vernon SW, Nadel MR, et al. Barriers to colorectal cancer screening: A comparison of reports from primary care physicians and average-risk adults. Med Care 2005; 43 (9): 939-44.
21. Dulai GS, Farmer MM, Ganz PA, et al. Primary care provider perceptions of barriers to and facilitators of colorectal cancer screening in a managed care setting. Cancer 2004; 100 (9): 1843-52.
22. Brouse CH, Basch CE, Wolf RL, et al. Barriers to colorectal cancer screening: An educational diagnosis. J Cancer Educ 2004; 19: 170-3.
23. Church TR, Yeazel MW, Jones RM, et al. A randomized trial of direct mailing of fecal occult blood tests to increase colorectal cancer screening. J Natl Cancer Inst 2004; 96 (10): 770-80.
24. Navarro M, Peris M, Binefa G, Nogueira JM, Miquel JM, Espinás JA, et al. Hallazgos colonoscópicos del estudio piloto de cribado del cáncer colorrectal realizado en Cataluña. Rev Esp Enferm Dig 2008; 100 (6): 343-8.